Acadian Asset Management LLC X Biotech Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$3.06 - $6.38 $55,643 - $116,013	-18,184 Reduced 75.3%	5,966 $35,000
Q1 2023 May 11, 2023	SELL	$3.22 - $4.72 $43,231 - $63,370	-13,426 Reduced 35.73%	24,150 $82,000
Q4 2022 Feb 14, 2023	SELL	$3.03 - $3.79 $23,858 - $29,842	-7,874 Reduced 17.32%	37,576 $130,000
Q3 2022 Nov 14, 2022	SELL	$3.58 - $5.88 $14,488 - $23,796	-4,047 Reduced 8.18%	45,450 $163,000
Q2 2022 Aug 09, 2022	BUY	$5.13 - $9.2 $253,919 - $455,372	49,497 New	49,497 $278,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.